Considering the pathological characteristics where accumulation of tau protein and neurodegeneration progress after Aβ accumulation in the brain, it is believed that more aggressive treatment at the stage where Aβ begins to accumulate can prevent cognitive decline by halting the progression to the next pathological stage [58,59]. This evidence concerns the gene MAPT and Mental deterioration.